Evaluation of CHI3L-1 and CHIT-1 expression in differentiated and polarized macrophages

Inflammation

Volumn 36, Issue 2, 2013, Pages 482-492

  Di Rosa, Michelino ^a   Malaguarnera, Giulia ^a   De Gregorio, Corinne ^a   Drago, Filippo ^a   Malaguarnera, Lucia ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

chitinase 3 like 1; chitotriosidase; differentiation; human monocyte macrophages; polarization

Indexed keywords

CHITINASE; CHITINASE 3 LIKE PROTEIN 1; CHITOTRIOSIDASE; MESSENGER RNA; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL POLARITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADIPOKINES; BASE SEQUENCE; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION; HEXOSAMINIDASES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-4; LECTINS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MOLECULAR SEQUENCE DATA; MONOCYTES; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; STAT1 TRANSCRIPTION FACTOR; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84879504327     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9569-8     Document Type: Article

References (53)

1. Johansen, J.S.; N.A. Schultz, and B.V. Jensen. 2009. Plasma YKL-40: A potential new cancer biomarker? Future Oncology 5: 1065-1082.
2. Volck, B.; P.A. Price, J.S. Johansen, O. Sorensen, T.L. Benfield, H.J. Nielsen, J. Calafat, and N. Borregarrd. 1998. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proceedings of the Association of American Physicians 110: 351-360.
3. Rehli, M.; H.H. Niller, C. Ammon, S. Langmann, L. Schwarzfischer, R. Andreesen, and S.W. Krause. 2003. Transcriptional regulation of CHI3L-1, a marker gene for late stages of macrophage differentiation. Journal of Biological Chemistry 278: 44058-44067.
4. Johansen, J.S.; H.S. Jensen, and P.A. Price. 1993. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. British Journal of Rheumatology 32: 949-955.
5. Malinda, K.M.; L. Ponce, H.K. Kleinman, L.M. Shackelton, and A.J. Millis. 1999. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Experimental Cell Research 250: 168-173.
6. Mizoguchi, E. 2006. Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells. Gastroenterology 130: 398-411.
7. Johansen, J.S.; M. Stoltenberg, M. Hansen, A. Florescu, K. Hørslev-Petersen, I. Lorenzen, and P.A. Price. 1999. Serum YKL-40 concentrations in patients with rheumatoid arthritis: Relation to disease activity. Rheumatology (Oxford, England) 38: 618-626.
8. Specjalski, K.; and E. Jassem. 2011. YKL-40 protein is a marker of asthma. The Journal of Asthma 48: 767-772.
9. Coffman, F.D. 2008. Chitinase 3-like-1 (CHI3L1): A putative disease marker at the interface of proteomics and glycomics. Critical Reviews in Clinical Laboratory Sciences 45: 531-562.
10. Johansen, J.S.; P.E. Hoyer, L.A. Larsen, P.A. Price, and K. Mollgard. 2007. YKL-40 protein expression in the early developing human musculoskeletal system. Journal of Histochemistry and Cytochemistry 55: 1213-1228.
11. Johansen, J.S. 2006. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Danish Medical Bulletin 53: 172-209.
12. Francescone, R.A.; S. Scully, M. Faibish, S.L. Taylor, D. Oh, L. Moral, W. Yan, B. Bentley, and R. Shao. 2011. Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. Journal of Biological Chemistry 286: 15332-15343.
13. Johansen, J.S.; S.E. Bojesen, A.K. Mylin, R. Frikke-Schmidt, P.A. Price, and B.G. Nordestgaard. 2009. Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population. Journal of Clinical Oncology 27: 572-578.
14. Kzhyshkowska, J.; S. Mamidi, A. Gratchev, E. Kremmer, C. Schmuttermaier, L. Krusell, G. Haus, J. Utikal, K. Schledzewski, J. Scholtze, and S. Goerdt. 2006. Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 107: 3221-3228.
15. Nielsen, A.R.; P. Plomgaard, K.S. Krabbe, J.S. Johansen, and B.K. Pedersen. 2011. IL-6, but not TNF-α, increases plasma YKL-40 in human subjects. Cytokine 55: 152-155.
16. Boot, R.G.; G.H. Renkema, A. Strijland, A.J. van Zonneveld, and J.M. Aerts. 1995. Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. Journal of Biological Chemistry 270: 26252-26256.
17. Bussink, A.P.; M. van Eijk, G.H. Renkema, J.M. Aerts, and R.G. Boot. 2006. The biology of the Gaucher cell: The cradle of human chitinases. International Review of Cytology 252: 71-128.
18. Brinkman, J.; F.A. Wijburg, C.E. Hollak, J.E. Groener, M. Verhoek, S. Scheij, J. Aten, R.G. Boot, and J.M. Aerts. 2005. Plasma chitotriosidase and CCL18: Early biochemical surrogate markers in type B Niemann-Pick disease. Journal of Inherited Metabolic Disease 28: 13-20.
19. Barone, R.; J. Simporé, L. Malaguarnera, S. Pignatelli, and S. Musumeci. Plasma chitotriosidase activity in acute Plasmodium falciparum malaria. Clinica Chimica Acta 331:79-85
20. Bargagli, E.; C. Maggiorelli, and P. Rottoli. 2008. Human chitotriosidase: A potential new marker of sarcoidosis severity. Respiration 76: 234-238.
21. Comabella, M.; C. Domínguez, J. Rio, P. Martín- Gallán, A. Vilches, N. Vilarrasa, C. Espejo, and X. Montalban. 2009. Plasma chitotriosidase activity in multiple sclerosis. Clinical Immunology 131: 216-222.
22. Boot, R.G.; T.A. van Achterberg, B.E. van Aken, G.H. Renkema, M.J. Jacobs, J.M. Aerts, and C.J. de Vries. 1999. Strong induction of members of the chitinase family of proteins in atherosclerosis: Chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology 19: 687-694.
23. Malaguarnera, L.; J. Simporè, D.A. Prodi, A. Angius, A. Sassu, I. Persico, R. Barone, and S. Musumeci. 2003. 24-bp duplication in exon 10 of human chitotriosidase gene from the sub-Saharan to the Mediterranean area: Role of parasitic diseases and environmental conditions. Genes and Immunity 4: 570-574.
24. Artieda, M.; A. Cenarro, A. Gañán, A. Lukic, E. Moreno, J. Puzo, M. Pocoví, and F. Civeira. 2007. Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-reactive protein. Cardiology 108: 297-306.
25. Palasik, W.; U. Fiszer, W. Lechowicz, B. Czartoryska, M. Krzesiewicz, and A. Lugowska. 2005. Assessment of relations between clinical outcome of ischemic stroke and activity of inflammatory processes in the acute phase based on examination of selected parameters. European Neurology 53: 188-193.
26. Di Rosa, M.; N. Dell'Ombra, A.M. Zambito, M. Malaguarnera, F. Nicoletti, and L. Malaguarnera. 2006. Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia. European Journal of Neuroscience 23: 2648-2656.
27. Malaguarnera, L.; M. Di Rosa, A.M. Zambito, N. dell'Ombra, F. Nicoletti, and M. Malaguarnera. 2006. Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut 55: 1313-1320.
28. Kzhyshkowska, J.; A. Gratchev, and S. Goerdt. 2007. Human chitinases and chitinase-like proteins as indicators for inflammation and cancer. Biomark Insights 2: 128-146.
29. Ross, R.; X.L. Ross, H. Ghadially, T. Lahr, J. Schwing, J. Knop, and A.B. Reske-Kunz. 1999. Mouse langerhans cells differentially express an activated T cell-attracting CC chemokine. Journal of Investigative Dermatology 113: 991-998.
30. Martinez, F.O.; A. Sica, and A.M. Mantovani Locati. 2008. Macrophage activation and polarization. Frontiers in Bioscience 13: 453-461.
31. Di Rosa, M.; A.M. Zambito, A.R. Marsullo, G. Li Volti, and L. Malaguarnera. 2009. Prolactin induces chitotriosidase expression in human macrophages through PTK, PI3-K, and MAPK pathways. Journal of Cellular Biochemistry 107: 881-881.
32. Fagone, P.; M. Di Rosa, M. Palumbo, C. De Gregorio, F. Nicoletti, and L. Malaguarnera. 2012. Modulation of heat shock proteins during macrophage differentiation. Inflammation Research 61: 1131-1139.
33. Quandt, K.; K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. MatInd and MatInspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Research 23: 4878-4884.
34. Heinemeyer, T.; X. Chen, H. Karas, A.E. Kel, O.V. Kel, I. Liebich, T. Meinhardt, I. Reuter, F. Schacherer, and E. Wingender. 1999. Expanding the TRANSFAC database towards an expert system of regulatory molecular mechanisms. Nucleic Acids Research 27: 318-322.
35. Klingenhoff, A.; K. Frech, K. Quandt, and T. Werner. 1999. Functional promoter modules can be detected by formal models independent of overall nucleotide sequence similarity. Bioinformatics 15: 180-186.
36. Frech, K.; J. Danescu-Mayer, and T. Werner. 1997. A novel method to develop highly specific models for regulatory units detects a new LTR in GenBank which contains a functional promoter. Journal of Molecular Biology 270: 674-687.
37. Malaguarnera, L.; M. Musumeci, M. Di Rosa, A. Scuto, and S. Musumeci. 2005. Interferon-gamma, tumor necrosis factor-alpha, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages. Journal of Clinical Laboratory Analysis 19: 128-132.
38. CakIr, G.; S. Gumus, E. Ucar, H. Kaya, E. Tozkoparan, E.O. Akgul, B. Karaman, O. Deniz, I. Kurt, M. Ozkan, and H. Bilgic. 2012. Serum chitotriosidase activity in pulmonary tuberculosis: Response to treatment and correlations with clinical parameters. Annals of Laboratory Medicine 32: 184-189.
39. Iyer, A.; M. van Eijk, E. Silva, M. Hatta, W. Faber, J.M. Aerts, and P.K. Das. 2009. Increased chitotriosidase activity in serum of leprosy patients: Association with bacillary leprosy. Clinical Immunology 131: 501-509.
40. Malaguarnera, L.; M. Di Rosa, A.M. Zambito, N. dell'Ombra, R. Di Marco, and M. Malaguarnera. 2006. Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution. American Journal of Gastroenterology 101: 2060-2069.
41. Malaguarnera, L.; L.N. Ohazuruike, C. Tsianaka, T. Antic, M. Di Rosa, and M. Malaguarnera. 2010. Human chitotriosidase polymorphism is associated with human longevity in Mediterranean nonagenarians and centenarians. Journal of Human Genetics 55: 8-12.
42. Di Rosa, M.; K. Mangano, C. De Gregorio, F. Nicoletti, and L. Malaguarnera. 2012. Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease. Hepatology Research. doi: 10.1111/j.1872-034X.2012.01063.x
43. Hu, B.; K. Trinh, W.F. Figueiira, and P.A. Price. 1996. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. Journal of Biological Chemistry 271: 19415-19420.
44. Nishikawa, K.C.; and A.J. Millis. 2003. gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Experimental Cell Research 287: 79-87.
45. Ku, B.M.; Y.K. Lee, J. Ryu, J.Y. Jeong, J. Choi, K.M. Eun, H.Y. Shin, D.G. Kim, E.M. Hwang, J.C. Yoo, J.Y. Park, G.S. Roh, H.J. Kim, G.J. Cho, W.S. Choi, S.H. Paek, and S.S. Kang. 2011. CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells. International Journal of Cancer 12: 1316-1326.
46. Lee, C.G.; C.A. Da Silva, C.S. Dela Cruz, F. Ahangari, B. Ma, M.J. Kang, C.H. He, S. Takyar, and J.A. Elias. 2011. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annual Review of Physiology 73: 479-482.
47. Bara, I.; A. Ozier, P.O. Girodet, G. Carvalho, J. Cattiaux, H. Begueret, M. Thumerel, O. Ousova, R. Kolbeck, A.J. Coyle, J. Woods, J.M. Tunon de Lara, R. Marthan, and P. Berger. 2012. Role of YKL-40 in bronchial smooth muscle remodeling in asthma. American Journal of Respiratory and Critical Care Medicine 185: 715-722.
48. Martinez, F.O.; L. Helming, and S. Gordon. 2009. Alternative activation of macrophages: An immunologic functional perspective. Annual Review of Immunology 27: 451-483.
49. Wynn, T.A.; and L. Barron. 2010. Macrophages: Master regulators of inflammation and fibrosis. Seminars in Liver Disease 30: 245-257.
50. Berry, A.; P. Balard, A. Coste, D. Olagnier, C. Lagane, H. Authier, F. Benoit-Vical, J.C. Lepert, J.P. Séguéla, J.F. Magnaval, P. Chambon, D. Metzger, B. Desvergne, W. Wahli, J. Auwerx, and B. Pipy. 2007. IL-13 induces expression of CD36 in human monocytes through PPAR gamma activation. European Journal of Immunology 37: 1642-1652.
51. Kang, K.; S.M. Reilly, V. Karabacak, M.R. Gangl, K. Fitzgerald, B. Hatano, and C.H. Lee. 2008. Adipocyte-derived Th2 cytokines and myeloid PPAR delta regulate macrophage polarization and insulin sensitivity. Cell Metabolism 7: 485-495.
52. Pourcet, B.; J.E. Feig, Y. Vengrenyuk, A. Hobbs, D. Kepka-Lenhart, M. Garabedian, S.M. Jr, E.A. Fisher Morris and I. Pineda-Torra. 2011. LXR{alpha} regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8. Circulation Research 109: 492-501.
53. Berres, M.L.; S. Papen, K. Pauels, P. Schmitz, M.M. Zaldivar, C. Hellerbrand, T. Mueller, T. Berg, R. Weiskirchen, C. Trautwein, and H.E. Wasmuth. 2009. A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL40 serum levels in chronic hepatitis C infection. Journal of Hepatology 50: 370-376.